Metastatic prostate cancer presenting as paraneoplastic pemphigus: A favourable clinical response to combined androgen blockade and conventional immunosuppressive therapy

British Journal of Dermatology

Volumn 160, Issue 2, 2009, Pages 468-470

  Mignogna, M D ^a   Fortuna, G ^a   Leuci, S ^a   Adamo, D ^a   Ruoppo, E ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Bicalutamide; Bone metastasis; Goserelin acetate; Paraneoplastic pemphigus; Prostate cancer

Indexed keywords

ALENDRONIC ACID; AZATHIOPRINE; BICALUTAMIDE; CALCIUM CARBONATE; COLECALCIFEROL; COMPLEMENT COMPONENT C3C; GOSERELIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PREDNISONE; PROSTATE SPECIFIC ANTIGEN; TAMSULOSIN;

AGED; ANTIANDROGEN THERAPY; BLOOD EXAMINATION; BONE SCINTISCANNING; CANCER GRADING; CANCER INFILTRATION; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMATURIA; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MALE; METASTASIS; NEEDLE BIOPSY; ORAL BIOPSY; PARANEOPLASTIC PEMPHIGUS; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; TREATMENT RESPONSE; ULTRASOUND; VESICULAR RASH;

AGED; ANDROGEN ANTAGONISTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PARANEOPLASTIC SYNDROMES; PEMPHIGUS; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 58349094126     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08982.x     Document Type: Letter

References (11)

1. Anhalt GJ, Kim SC, Stanley JR et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990 323 : 1729 35.
2. Kaplan I, Hodak E, Ackerman L et al. Neoplasms associated with paraneoplastic pemphigus: a review with emphasis on non-hematologic malignancy and oral mucosal manifestations. Oral Oncol 2004 40 : 553 62.
3. Amagai M, Nishikawa T, Nousari HC et al. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. J Clin Invest 1998 102 : 775 82.
4. Zhu X, Zhang B. Paraneoplastic pemphigus. J Dermatol 2007 34 : 503 11.
5. Billet SE, Grando SA, Pittelkow MR. Paraneoplastic autoimmune multiorgan syndrome: review of the literature and support for a cytotoxic role in pathogenesis. Autoimmunity 2006 39 : 617 30.
6. Nousari HC, Kimyai-Asadi A, Anhalt GJ. Elevated serum levels of interleukin-6 in paraneoplastic pemphigus. J Invest Dermatol 1999 112 : 396 8.
7. Seishima M, Oda M, Oyama Z et al. Antibody titers to desmogleins 1 and 3 in a patient with paraneoplastic pemphigus associated with follicular dendritic cell sarcoma. Arch Dermatol 2004 140 : 1500 3.
8. Chan LS. Epitope spreading in paraneoplastic pemphigus: autoimmune induction in antibody-mediated blistering skin diseases. Arch Dermatol 2000 136 : 663 4.
9. Nagle RB, Knox JD, Wolf C et al. Adhesion molecules, extracellular matrix, and proteases in prostate carcinoma. J Cell Biochem 1994 19 (Suppl. 232 7.
10. Martel P, Gilbert D, Labeille B et al. A case of paraneoplastic pemphigus with antidesmoglein 1 antibodies as determined by immunoblotting. Br J Dermatol 2000 142 : 812 13.
11. Antal AS, Grieb S, Homey B et al. Paraneoplastic bullous pemphigoid in a man with breast and prostate cancer. Hautarzt 2007 58 : 833 4.